These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7048246)

  • 21. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.
    Vinik AI; Bril V; Kempler P; Litchy WJ; Tesfaye S; Price KL; Bastyr EJ;
    Clin Ther; 2005 Aug; 27(8):1164-80. PubMed ID: 16199243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of cyclandelate on diabetic peripheral neuropathy.
    Canal N; Comi G; Marchettini P; Pozza G
    Br J Clin Pract Suppl; 1984; 34():62-8. PubMed ID: 6430326
    [No Abstract]   [Full Text] [Related]  

  • 23. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.
    Yuan RY; Sheu JJ; Yu JM; Chen WT; Tseng IJ; Chang HH; Hu CJ
    Neurology; 2009 Apr; 72(17):1473-8. PubMed ID: 19246421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Imipramine in the treatment of painful diabetic neuropathy of the extremities].
    Kvinesdal B; Molin J; Frøland A; Gram LF
    Ugeskr Laeger; 1983 Sep; 145(39):3018-9. PubMed ID: 6359618
    [No Abstract]   [Full Text] [Related]  

  • 25. Therapeutic trial of isaxonine in Duchenne muscular dystrophy.
    Heckmatt JZ; Hyde SA; Gabain A; Dubowitz V
    Muscle Nerve; 1988 Aug; 11(8):836-47. PubMed ID: 3050510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy. A preliminary report.
    Valensi P; Le Devehat C; Richard JL; Farez C; Khodabandehlou T; Rosenbloom RA; LeFante C
    J Diabetes Complications; 2005; 19(5):247-53. PubMed ID: 16112498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The electrophysiological findings of subclinical neuropathy in patients with recently diagnosed type 1 diabetes mellitus.
    Karsidag S; Morali S; Sargin M; Salman S; Karsidag K; Us O
    Diabetes Res Clin Pract; 2005 Mar; 67(3):211-9. PubMed ID: 15713353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin E1 in lipid microspheres ameliorates diabetic peripheral neuropathy: clinical usefulness of Semmes-Weinstein monofilaments for evaluating diabetic sensory abnormality.
    Akahori H; Takamura T; Hayakawa T; Ando H; Yamashita H; Kobayashi K
    Diabetes Res Clin Pract; 2004 Jun; 64(3):153-9. PubMed ID: 15126001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral zinc therapy in diabetic neuropathy.
    Gupta R; Garg VK; Mathur DK; Goyal RK
    J Assoc Physicians India; 1998 Nov; 46(11):939-42. PubMed ID: 11229219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antidepressive agents in the treatment of diabetic neuropathy.
    Kvinesdal B; Molin J; Frøland A; Gram LF
    Clin Physiol; 1985; 5 Suppl 5():97-100. PubMed ID: 3914393
    [No Abstract]   [Full Text] [Related]  

  • 31. Trial of ganglioside therapy for diabetic neuropathy.
    Hallett M; Flood T; Slater N; Dambrosia J
    Muscle Nerve; 1987; 10(9):822-5. PubMed ID: 3683453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does anodyne light therapy improve peripheral neuropathy in diabetes? A double-blind, sham-controlled, randomized trial to evaluate monochromatic infrared photoenergy.
    Lavery LA; Murdoch DP; Williams J; Lavery DC
    Diabetes Care; 2008 Feb; 31(2):316-21. PubMed ID: 17977931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of isaxonine on experimentally induced vincristine neuropathy in rabbits (author's transl)].
    Kowa H; Saito T
    Nouv Presse Med; 1982 Apr; 11(16):1246-9. PubMed ID: 6285278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of 3-month treatment with the antioxidant alpha-lipoic acid in diabetic peripheral neuropathy.
    Negrişanu G; Roşu M; Bolte B; Lefter D; Dabelea D
    Rom J Intern Med; 1999; 37(3):297-306. PubMed ID: 15532308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheric and automatic neuropathy in children with type 1 diabetes mellitus: the effect of L-carnitine treatment on the peripheral and autonomic nervous system.
    Uzun N; Sarikaya S; Uluduz D; Aydin A
    Electromyogr Clin Neurophysiol; 2005; 45(6):343-51. PubMed ID: 16315971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.
    Ziegler D; Ametov A; Barinov A; Dyck PJ; Gurieva I; Low PA; Munzel U; Yakhno N; Raz I; Novosadova M; Maus J; Samigullin R
    Diabetes Care; 2006 Nov; 29(11):2365-70. PubMed ID: 17065669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic importance of detecting mild sensory impairment in leprosy: a randomized controlled trial (TRIPOD 2).
    Van Brakel WH; Anderson AM; Withington SG; Croft RP; Nicholls PG; Richardus JH; Smith WC
    Lepr Rev; 2003 Dec; 74(4):300-10. PubMed ID: 14750575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study.
    Stracke H; Gaus W; Achenbach U; Federlin K; Bretzel RG
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):600-5. PubMed ID: 18473286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of an aldose reductase inhibitor, epalrestat, on diabetic neuropathy. Clinical benefit and indication for the drug assessed from the results of a placebo-controlled double-blind study.
    Goto Y; Hotta N; Shigeta Y; Sakamoto N; Kikkawa R
    Biomed Pharmacother; 1995; 49(6):269-77. PubMed ID: 7579007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of diabetic neuropathy with oral alpha-lipoic acid (author's transl)].
    Klein W
    MMW Munch Med Wochenschr; 1975 May; 117(22):957-8. PubMed ID: 807811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.